
About Dr. Vishwanath S.
- Dr. Vishwanath is a well-accomplished Medical Oncologist having more than 6 years of experience.
- He holds extensive experience in Lymphoma/ Multiple Myeloma, Leukemias, and solid cancers (Breast, Gynaecological, Lung, Head and Neck, GI and Sarcomas).
- After completing graduate studies, he pursued DM in Medical Oncology from Kidwai Memorial Institute of Oncology followed by MD in Internal Medicine from Kasturba Medical College.
- He has over 40 papers and publications in national and international journals.
- He has been honored with various awards and recognitions including an Abstract Achievement Award from the American Society of Hematology (ASH).
MD, Internal Medicine (Kasturba Medical College)
DM, Medical Oncology (Kidwai Memorial Institute of Oncology)
2018 – Conferred Professorship by Apollo Hospitals Education and Research Foundation. 2016 – ASH Abstract Achievement Award (Oral abstract at ASH 2016). 2016 – (ASCO Post): Combination Obinutuzumab Regimen Promising in Aggressive Diffuse Large B-Cell Lymphoma: Lead author. 2016 – ASH Clinical News, Volume 2, Issue 8. R-EPOCH May Be a Viable Option for Patients with High-Risk DLBCL: Lead author. 2016 – Travel Grant, Pan Pacific Lymphoma Conference, Kauai July 18-21, 2016. 2015- Gold Medal DM Medical Oncology, Kidwai Memorial Institute of Oncology,Rajiv Gandhi University of Health Sciences, Bangalore, India. 2014- Consolation Prize: Outcomes in GCB vs. Non GCB DLBCL from a tertiary care center in South India: SAARC International Conference of SAARC Federation of Oncologists, 28-30 Nov 2014 University, Manipal, India. 2008- Gold Medal, MD General Medicine, Kasturba Medical College, Manipal. 2006-Oral Presentation: Melioidosis, an emerging infectious disease – Association of Physicians of India, Karnataka Chapter, Bangalore, India2004-Neurology Quiz (2nd Place), NIMHANS, Bangalore, Karnataka, India.
Associate Professor, Department of Internal Medicine, Kasturba Medical College, Manipal University, Manipal, India
Clinical Fellow in the Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA where he received training from global experts in Medical Oncology.
Diplomate of National Board (DNB)Teacher, Apollo Hospitals and Education Research Foundation (AHERF)
Consultant, Apollo Speciality Hospital, Jayanagar(2026)
Papers Published
- Vishwanath Sathyanarayanan, Christopher Flowers and Swaminathan Iyer. Comparison of Access to Novel Drugs for Lymphoma and Chronic Lymphocytic Leukemia Between India and the United States JCO Global Oncology no. 6 (2020) 1124-1133. Published online July 21, 2020.
+ Read More- Show Less
- Vishwanath Sathyanarayanan, Amir Issa, Raisa Pinto et al. Rosai Dorfman Disease: MD Anderson Cancer Center Experience. Clin Lymphoma Myel Leukemia. July 2019.
- Vishwanath Sathyanarayanan, Wai Chin Foo, Michelle Fanale, Jason Robert Westin. Deeper insights into Vanishing Bile Duct Syndrome in lymphoma: A Perplexing Entity http://dx.doi.org/10.1016/j.clml.2016.02.035
- Sathyanarayanan V, Neelapu SS. Cancer immunotherapy: Strategies for personalization and combinatorial approaches.Mol Oncol. 2015 Dec;9(10):2043-53.
- Sathyanarayanan V, Hagemeister F. Targeted therapies for Hodgkin lymphoma: results of recent trials. Rinsho Ketsueki 57(10):2049-2053, 2016. PMID: 27795513.
- B.K. Govind, K.C. Lakshmaiah, D. Lokanatha, B.Suresh, C.S. Premalata, C.R. Rao, L.J.Abraham, K.N. Lokesh, L, K. Rajeev, V. Arroju, V. Sathyanarayanan. Primary Parotid Lymphoma from a regional cancer center in South India. The Gulf Journal of Oncology. Issue no. 20- Jan 2016.
Send Your Enquiry
Fill in your details and our medical experts will contact you within 24 hours.
Want to consult the doctor?
Don't Ignore Your Health!
Other Top Medical Oncologist In Bangalore


Dr. Amit Rauthan


